Searched for
SUN PHARMA Q1 REVENUE
HDFC Bank Q1 business update: Gross advances rise 15% to Rs 30.61 lakh croreHDFC Bank has announced robust financial results for the April-June quarter of FY27. Gross advances surged 15.4% year-on-year to Rs 30.61 l...- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- Dabur Q1 updates: Co expects double-digit revenue growth as rural demand stays ahead of urbanDabur India anticipates a significant boost in its first-quarter profit, driven by strategic price hikes that effectively countered rising ...
- India's Godrej Consumer expects volume-driven first-quarter revenue riseGodrej Consumer anticipates a robust first quarter, projecting high-teen consolidated revenue growth driven by solid underlying volume incr...
- HCL Tech surges 6% on $1.14 billion AI deal; Mercedes-Benz likely clientHCL Tech shares surged following a significant $1.14 billion deal with a European Fortune Global 50 firm to manage its digital workplace an...
- PC Jeweller shares rally 5% after Q1 update; firm eyes debt-free status this quarterPC Jeweller shares are likely to remain in focus after the company reported a 21% rise in Q1 FY27 revenue and said it expects to become deb...
- Avenue Supermarts shares tumble 5% after posting Q1 business updateAvenue Supermarts, operator of DMart, saw its shares dip 5% despite reporting a 15.1% revenue increase to Rs 18,343.5 crore for the June qu...
- KPIT outlook disappoints, analysts push growth recovery to FY28KPIT Technologies shares tumbled nearly 17% after issuing a weaker-than-expected outlook for FY27. European automakers, facing profitabilit...
- FirstCry shares in focus ahead of Rs 300 crore Swara Baby stake sale via IPOBrainbees Solutions, the parent of FirstCry, will see its shares in focus after approving a Rs 300 crore offer for sale (OFS) in its subsid...
- Macros, AI, geopolitical overhang to drag Q1 showing of IT cos: Motilal OswalIndian IT firms are bracing for a subdued first quarter of FY27, with global economic headwinds, AI's impact, and geopolitical tensions dam...
- Explained: Why Tata Elxsi shares crashed 7% after KPIT Tech’s Q1 revenue, profit guidance warningTata Elxsi shares fell sharply on Wednesday after rival KPIT Technologies warned of weaker-than-expected Q1FY27 revenue and margins due to ...
- KPIT Tech shares hit by downgrades, target price cuts. What JPMorgan and other brokerages saidKPIT Technologies shares plunged after the company issued a weak preliminary Q1 FY27 business update, prompting several brokerages, includi...
- KPIT Tech shares sink 17%, see worst plunge since 2020 Covid crash. Time to buy or more pain ahead?KPIT Technologies shares dropped to a fresh 52-week low on Wednesday after the company warned of weaker-than-expected Q1 FY27 revenue and m...
- Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
- KPIT Tech shares crash 17% as company expects Q1 revenue decline, sharp hit to marginsKPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
